IRLAB Therapeutics AB Class A documents

Explore the latest documents from IRLAB Therapeutics AB Class A, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.

Description

Event date

Documents and forms

2025

Q2 2025

Aug 27, 2025

Transcript

Interim report

Q1 2025

May 7, 2025

Transcript

Interim report

Study Update

Mar 28, 2025

Press release

Study Result

Mar 5, 2025

Press release

2024

Q4 2024

Feb 12, 2025

Transcript

Annual report

Interim report

Q3 2024

Oct 30, 2024

Interim report

Q2 2024

Jul 10, 2024

Interim report

Q1 2024

May 8, 2024

Slides

Interim report

2023

Q4 2023

Feb 7, 2024

Annual report

Slides

Interim report

Q3 2023

Oct 25, 2023

Slides

Interim report

CMD 2023

Oct 17, 2023

Slides

Q2 2023

Aug 30, 2023

Slides

Interim report

Study Update

Aug 22, 2023

Press release

Q1 2023

May 10, 2023

Slides

Interim report

2022

Q4 2022

Feb 23, 2023

Annual report

Slides

Interim report

Q3 2022

Nov 9, 2022

Interim report

Slides

Q2 2022

Aug 24, 2022

Interim report

Slides

Q1 2022

May 11, 2022

Interim report

Slides

2021

Q4 2021

Feb 23, 2022

Annual report

Interim report

Q3 2021

Nov 10, 2021

Interim report

Licensing Agreement

Jul 16, 2021

Press release

2020

Q4 2020

Apr 15, 2021

Annual report

2019

Q4 2019

Apr 7, 2020

Annual report

2018

Q4 2018

Apr 3, 2019

Annual report

2017

Q4 2017

Apr 19, 2018

Annual report